Form 4: IN8BIO Director Whitfill Acquires Stock Options
SEC Form 4 Filing
Director Travis Whitfill acquired stock options in IN8BIO, INC. on December 19, 2024.
Summary
- On December 19, 2024, Travis Whitfill, a director of IN8BIO, INC., acquired 42,676 stock options with an exercise price of $0.24.
- These options vest on December 19, 2025, contingent upon continued service.
- Following the transaction, Whitfill directly owns 42,676 derivative securities.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard regulatory filing. The acquisition of stock options by a director is generally viewed as a slightly positive signal, but it's not a major event.
Positives
- A director's acquisition of stock options can be seen as a positive sign, indicating confidence in the company's future prospects.
Industry Context
This is a standard SEC Form 4 filing, reflecting a change in beneficial ownership by a company insider. Such filings are common and provide transparency to the market.
Stakeholder Impact
- The acquisition of stock options by a director could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 12/19/2024 | Date of the stock option acquisition. |
| 12/19/2025 | Vesting date of the stock options. |
| 12/19/2034 | Expiration date of the stock options. |
| 12/23/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.